Trial Profile
Efficacy of dolutegravir in patients with HIV-2 infection: A retrospective observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-2 infections
- Focus Therapeutic Use
- 18 Mar 2016 Status changed from not stated to completed.
- 18 Mar 2016 New trial record